Literature DB >> 7420146

Mechanism of cerebral arterial contraction induced by blood constituents.

N Toda, K Shimizu, T Ohta.   

Abstract

In helically cut stips of cerebral, coronary, mesenteric, and renal arteries from dogs, a test solution containing hemoglobin (Hb) and soluble constituents, obtained by exposure of blood clot to distilled water, produced a dose-related contraction. The contraction of cerebral arteries was greater than that of the other arteries. Methemoglobin (metHb) caused only a slight contraction. The contractile response of cerebral arteries to the Hb-containing test solution was attenuated by aspirin (10(-5) to 2 X 10(-4) M), polypholretin phosphate (PPP, 3 X 10(-5) gm/ml), a prostaglandin (PG) antagonist, and cinanserin (10(-7) M), a serotonin antagonist. Combined treatment with these antagonists suppressed the response to the test solution, but only slightly attenuated contractions induced by K+. Phentolamine was ineffective. Contractions of measenteric arterial strips induced by the test solution were potentiated by aspirin, but were attenuated by PPP and cinanserin. Serum also produced contractions of cerebral and mesenteric arteries, which were attenuated by treatment with cinanserin or PPP. Contractile responses to Hb-containing solution and serum obtained from dogs pretreated with reserpine were weaker than those to the solutions obtained from control dogs. It may be concluded that the Hb-containing test solution releases vasoconstricting PG's from the cerebral arterial wall but vasodilating PG's from mesenteric arteries. The test solution appears to contain vasconstricting PG's and serotonin. Serum-induced contractions appear to be mediated mainly by serotonin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7420146     DOI: 10.3171/jns.1980.53.3.0312

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  Investigation of the vasoconstrictor action of subarachnoid haemoglobin in the pig cerebral circulation in vivo.

Authors:  J V Byrne; T M Griffith; D H Edwards; T J Harrison; K R Johnston
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

2.  Factors inducing endothelium-dependent relaxation in the guinea-pig basilar artery as estimated from the actions of haemoglobin.

Authors:  E Nishiye; K Nakao; T Itoh; H Kuriyama
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

3.  Hemoglobin penetration in the wall of the rabbit basilar artery after subarachnoid hemorrhage and intracisternal hemoglobin injection.

Authors:  P L Foley; N F Kassell; S B Hudson; K S Lee
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

4.  Role of heme oxygenase in heme-mediated inhibition of rat brain Na+-K+-ATPase: protection by tin-protoporphyrin.

Authors:  R D Levere; B Escalante; M L Schwartzman; N G Abraham
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

5.  The calibre of cerebral arteries of the rat studied by carotid angiography: a model system for studying the aetiology of human cerebral arterial constriction after aneurysmal rupture.

Authors:  D J Boullin; V Aitken; G H du Boulay; P Tagari
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

6.  Potassium currents of rat basilar artery smooth muscle cells.

Authors:  N Stockbridge; H Zhang; B Weir
Journal:  Pflugers Arch       Date:  1992-05       Impact factor: 3.657

7.  The pathophysiology of cerebral vasospasm, and pharmacological approaches to its management.

Authors:  R Towart
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

Review 8.  Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential.

Authors:  Ardalan Zolnourian; Ian Galea; Diederik Bulters
Journal:  Oxid Med Cell Longev       Date:  2019-05-02       Impact factor: 6.543

Review 9.  Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage.

Authors:  Liam Flynn; Peter Andrews
Journal:  F1000Res       Date:  2015-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.